Luseogliflozin

DB12214

small molecule investigational

Deskripsi

Luseogliflozin has been used in trials studying the treatment of Diabetes Melltius, Type 2.

Struktur Molekul 2D

Berat 434.55
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

629 Data
Pegvisomant The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Luseogliflozin.
Lipoic acid The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Luseogliflozin.
Moxifloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Moxifloxacin.
Grepafloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Grepafloxacin.
Enoxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Enoxacin.
Pefloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Pefloxacin.
Ciprofloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Ciprofloxacin.
Trovafloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Trovafloxacin.
Nalidixic acid The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Nalidixic acid.
Rosoxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Rosoxacin.
Cinoxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Cinoxacin.
Lomefloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Lomefloxacin.
Gatifloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Gatifloxacin.
Norfloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Norfloxacin.
Levofloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Levofloxacin.
Gemifloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Gemifloxacin.
Ofloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Ofloxacin.
Sparfloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Sparfloxacin.
Temafloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Temafloxacin.
Fleroxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Fleroxacin.
Technetium Tc-99m ciprofloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Technetium Tc-99m ciprofloxacin.
Garenoxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Garenoxacin.
Nemonoxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Nemonoxacin.
Flumequine The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Flumequine.
Enrofloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Enrofloxacin.
Orbifloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Orbifloxacin.
Sarafloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Sarafloxacin.
Difloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Difloxacin.
Pazufloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Pazufloxacin.
Prulifloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Prulifloxacin.
Delafloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Delafloxacin.
Sitafloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Sitafloxacin.
Oxolinic acid The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Oxolinic acid.
Rufloxacin The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Rufloxacin.
Pipemidic acid The therapeutic efficacy of Luseogliflozin can be increased when used in combination with Pipemidic acid.
Methyclothiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Methyclothiazide.
Chlorthalidone The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Chlorthalidone.
Bendroflumethiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Bendroflumethiazide.
Metolazone The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Metolazone.
Benzthiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Benzthiazide.
Hydroflumethiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Hydroflumethiazide.
Indapamide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Indapamide.
Chlorothiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Chlorothiazide.
Hydrochlorothiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Hydrochlorothiazide.
Trichlormethiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Trichlormethiazide.
Polythiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Polythiazide.
Quinethazone The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Quinethazone.
Cyclopenthiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Cyclopenthiazide.
Epitizide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Epitizide.
Amitriptyline Amitriptyline may decrease the hypoglycemic activities of Luseogliflozin.
Protriptyline Protriptyline may decrease the hypoglycemic activities of Luseogliflozin.
Imipramine Imipramine may decrease the hypoglycemic activities of Luseogliflozin.
Nortriptyline Nortriptyline may decrease the hypoglycemic activities of Luseogliflozin.
Amoxapine Amoxapine may decrease the hypoglycemic activities of Luseogliflozin.
Trimipramine Trimipramine may decrease the hypoglycemic activities of Luseogliflozin.
Doxepin Doxepin may decrease the hypoglycemic activities of Luseogliflozin.
Desipramine Desipramine may decrease the hypoglycemic activities of Luseogliflozin.
Clomipramine Clomipramine may decrease the hypoglycemic activities of Luseogliflozin.
Amineptine Amineptine may decrease the hypoglycemic activities of Luseogliflozin.
Dimetacrine Dimetacrine may decrease the hypoglycemic activities of Luseogliflozin.
Butriptyline Butriptyline may decrease the hypoglycemic activities of Luseogliflozin.
Dosulepin Dosulepin may decrease the hypoglycemic activities of Luseogliflozin.
Tianeptine Tianeptine may decrease the hypoglycemic activities of Luseogliflozin.
Oxaprotiline Oxaprotiline may decrease the hypoglycemic activities of Luseogliflozin.
Opipramol Opipramol may decrease the hypoglycemic activities of Luseogliflozin.
Amitriptylinoxide Amitriptylinoxide may decrease the hypoglycemic activities of Luseogliflozin.
Dibenzepin Dibenzepin may decrease the hypoglycemic activities of Luseogliflozin.
Quinupramine Quinupramine may decrease the hypoglycemic activities of Luseogliflozin.
Melitracen Melitracen may decrease the hypoglycemic activities of Luseogliflozin.
Lofepramine Lofepramine may decrease the hypoglycemic activities of Luseogliflozin.
Iprindole Iprindole may decrease the hypoglycemic activities of Luseogliflozin.
Imipramine oxide Imipramine oxide may decrease the hypoglycemic activities of Luseogliflozin.
Dapagliflozin Dapagliflozin may increase the hypoglycemic activities of Luseogliflozin.
Canagliflozin Canagliflozin may increase the hypoglycemic activities of Luseogliflozin.
Empagliflozin Empagliflozin may increase the hypoglycemic activities of Luseogliflozin.
Ertugliflozin Ertugliflozin may increase the hypoglycemic activities of Luseogliflozin.
Leuprolide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Leuprolide.
Goserelin The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Goserelin.
Octreotide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Octreotide.
Torasemide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Torasemide.
Nelfinavir The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Nelfinavir.
Indinavir The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Indinavir.
Ziprasidone The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Ziprasidone.
Phenytoin The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Phenytoin.
Etonogestrel The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Etonogestrel.
Desogestrel The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Desogestrel.
Fluorometholone The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Luseogliflozin.
Olanzapine The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Olanzapine.
Megestrol acetate The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Megestrol acetate.
Clozapine The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Clozapine.
Levonorgestrel The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Levonorgestrel.
Beclomethasone dipropionate The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Luseogliflozin.
Progesterone The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Progesterone.
Betamethasone The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Luseogliflozin.
Chlorpromazine The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Chlorpromazine.
Haloperidol The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Haloperidol.
Ritonavir The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Ritonavir.
Piperazine The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Piperazine.
Medroxyprogesterone acetate The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Medroxyprogesterone acetate.
Cyclothiazide The therapeutic efficacy of Luseogliflozin can be decreased when used in combination with Cyclothiazide.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul